Asterion is pleased to announce the voting results from the Company's 2020 annual general meeting of shareholders held on Friday,...
EyePoint and Ocumension announced a license agreement for a post-operative inflammation treatment following ocular surgery in Asia.
Antares announced its 2020 net revenue guidance of US$135 to US$155 million, which includes potential revenue scenarios for AMAG’s Makena.
Naturally Splendid Enterprises Ltd. (“Naturally Splendid”, “NSE” or “the Company”) (FRANKFURT:50N) (TSXV:NSP) (OTC:NSPDF) provides the following updates. The Company has...
Meridian announced the launch of a High-Specificity Pfu HS Mix that provides high-fidelity amplification for CDx and clinical testing.
OncoSec has purchased a multi-year Phesi ClinSite license to enable more precise planning for clinical trials of anticancer immunotherapies.
Cidara Therapeutics commenced the previously announced rights offering to raise gross proceeds of approximately US$30 million.